Tradewind Bioscience

 

  Follow

Location: USA

Founded in 2017

Privately Held


Develops targeted cancer therapies by focusing on a unique oncogene, which produces a secreted protein highly expressed in cancer cells but not adult tissues, correlating with cancer aggressiveness.
"Tradewind scientists have identified an oncogene that is a little different than the mutated kinases and amplified genes we normally think of as oncogenes. Our first drug target is a secreted protein, that comes to be highly expressed in cancer cells, whereas it is not expressed in adult tissues. It can initiate cancer in transgenic mouse models, enable ascites growth and dissemination to distant organs and is important to maintain tumor cell survival and proliferation in tumors that evolve high expression. Expression correlates with the aggressiveness of human cancer. "
Description Source: VentureRadar Research / Company Website

Updates


Biotech Showcase 2022
Conference
09 Jan 2022
One of Presenting Companies
US Small Business Administration (SBA) Award
Grant
31 Dec 2021
Amount: $405,552.00 | Development of a Therapeutic Monoclonal Antibody Against EGFL6, a Mediator of Tumor Growth and Metastasis
Venture-funding News
Equity Funding
21 Mar 2018
64 startups launch at Y Combinator’s W18 Demo Day 2
View Funding Rounds for Keywords: Biotechnology; Antibodies; Drug Discovery; Immuno-Oncology; Biologics

Funding Signals


Export Similar Companies

Similar Companies


Company Country Status Description
Aulos BioscienceUSAPrivately Held
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics. Aulos was created by ATP, a leading life science...
Alloy TherapeuticsUSAPrivately Held
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, we...
NectinIsraelPrivately Held
Nectin Therapeutics is an early-stage company established in 2017 based on a collaboration of the Hebrew University of Jerusalem and the University of Rijeka, Croatia. At Nectin,...
BIOMUNEXFrancePrivately Held
BIOMUNEX Pharmaceuticals is a biopharmaceutical company focused on developing therapeutics in the area of immuno-oncology through the discovery and development of innovative...
HumanigenUSAn/a
We are a clinical stage biopharmaceutical company, developing our immunology and immuno-oncology portfolio of monoclonal antibodies. We are focusing our efforts on the development...
Show all
VentureRadar Score

Is this your company?

Claim this profile and
update details for free
Sub-Scores
Social Proof
750
Website Traffic
n/a
Auto Analyst Score
430
Popularity on VentureRadar
931
Auto Analyst Score
43
Auto Analyst Score: 43 | tradewindbio.com
VentureRadar Popularity
High
VentureRadar Popularity: High
The popularity score combines profile views, clicks and the number of times the company appears in search results.

Free Sign-up for VentureRadar access

or






By continuing, you agree to VentureRadar's Terms of Service, Privacy Policy and Cookie Policy.

To continue, please confirm you are not a robot